ABSTRACT: Vertebral compression fractures are caused by many factors including trauma and osteoporosis. Osteoporosis induced fractures are a result of loss in bone mass and quality that weaken the vertebral body. Vertebroplasty and kyphoplasty, involving cement augmentation of fractured vertebrae, show promise in restoring vertebral mechanical properties. Some complications however, are reported due to the performance characteristics of commercially available bone cements. In this study, the biomechanical performance characteristics of two novel composite (PMMA-CaP) bone cements were studied using an anatomically accurate human cadaveric vertebroplasty model. The study involves mechanical testing on two functional cadaveric spinal unit (2FSU) segments which include monotonic compression and cyclical fatigue tests, treatment by direct cement injection, and microscopic visualization of sectioned vertebrae. The 2FSU segments were fractured, treated, and mechanically tested to investigate the stability provided by two novel bone cements; using readily available commercial acrylic cement as a control. Segment height and stiffness were tracked during the study to establish biomechanical performance. The 2FSU segments were successfully stabilized with all three cement groups. Stiffness values were restored to initial levels following fatigue loading. Cement interdigitation was observed with all cement groups. This study demonstrates efficient reinforcement of the fractured vertebrae through stiffness restoration. The pre-mixed composite cements were comparable to the commercial cement in their performance and interdigitative ability, thus holding promise for future clinical use. ß
Osteoporosis, a condition characterized by age-related reductions in bone mass and strength, is the cause of approximately 1.5 million orthopaedic fractures that occur each year in the United States. 1 The majority of the fractures happen in the spine, with about 700,000 cases annually in the United States. 2, 3 Vertebral compression fractures (VCFs) are serious injuries, hampering movement, and causing pain, ultimately degrading a patient's quality of life.
Abnormal mechanical forces on the spine can make it susceptible to the loss of bone mass. 4 The vertebrae can resist the compressive loads acting along the spinal axis, and this resistive property can be attributed to the dense trabecular network within the vertebral body (VB). This trabecular structure adapts to the load distribution through normal bone remodeling process regulated by osteocytes, osteoblasts, and osteoclasts. 2, 4 In some circumstances, the remodeling mechanism can fault and create reductions in bone mass in some areas of the VB increasing the susceptibility of the vertebrae to fracture. Understanding the structural aspects of the vertebrae can help in the analysis of VCFs. Bone mineral density (BMD) is a current clinical measure used to study and diagnose osteoporosis.
Vertebroplasty (VP) and kyphoplasty are minimally invasive techniques which involve the direct injection of bone cement into the fractured VB. These procedures have shown promising results with quick patient pain relief. [5] [6] [7] [8] [9] The VB is stabilized through the cement augmentation, with vertebral height restoration reported with kyphoplasty. Despite this, some complications have been reported such as pulmonary emboli formation due to cement extravasation. [10] [11] [12] [13] [14] The cause of these problems can be attributed to some shortcomings associated with commercially available acrylic bone cements. These cements lack osseointegrative ability due to the bioinert nature of the acrylic polymer. Addition of calcium phosphate (CaP) to the cement, an attempt to introduce bioactivity, has been reported to cause complications with handling properties and mechanical strength. [15] [16] [17] Current bone cements are also suboptimal for rapid application as they are provided as powder-liquid formulations requiring mixing in the operating room. This requires a waiting time and poses a delay in the surgical procedure as the surgeon waits for the cement to increase its viscosity and reach a suitable doughy state. An important trade-off is that the higher the viscosity, the more difficult the cement injection, whereas the lower the viscosity; the higher the risk of cement extravasation.
Recently, a pre-mixed cement system has been reported in the literature with the versatility to be tailored for specific applications. [18] [19] [20] The system can incorporate CaP fillers imparting bioactive properties upon the cement without the aforementioned detrimental effects. [18] [19] [20] It also has superior rheological properties compared to commercial cements, making injection easier at high viscosities, thereby decreasing the risk of extravasation. [18] [19] [20] The pre-mixed system allows the cement to reach full swelling thus enabling the completein corporation of CaP fillers. [18] [19] [20] Recent studies report the performance and efficiency of two composite cements, polymethylmethacrylate-hydroxyapatite (PMMA-HA) and PMMA-brushite, in an in vitro porcine vertebroplasty model. [18] [19] [20] These composite cements were shown to successfully stabilize the fractured porcine VBs and were able to withstand cyclic fatigue loading, however the pre-mixed cements have not been tested using cadavers.
The work performed in this study further investigates these pre-mixed composite cements in a more anatomically relevant human cadaveric vertebroplasty model. Outcomes studied include VB height restoration, stiffness, and fill success including extravasation and cement interdigitation. Comparisons are made to an approved, commercially available, PMMA bone cement, Kyphon 1 HV-R 1 (herein designated as PMMA-K). The composite cements are hypothesized to provide adequate augmentation through stiffness restoration of the fractured cadaveric vertebrae.
MATERIALS AND METHODS

Materials
All chemicals were used as received from the manufacturers without any further modification. PMMA (Monomer-Polymer and Dajac Lab, Trevose, PA) (80,000 g/mol) with 100-200 mm particle size was used as an aid to increase the viscosity of the cement mixture. Methyl methacrylate (MMA) (Fisher Scientific, Waltham, MA) was used as the monomer for the mixture. N,N-dimethyl p-toluidine (DMPT) (Sigma-Aldrich, St. Louis, MO) and Benzoyl Peroxide (BPO) (Sigma-Aldrich) were used as the activator and initiator, respectively, of the free radical polymerization reaction. HA (Sigma-Aldrich), and Brushite (Fisher) were used as the calcium phosphate filler additives in the two cements, respectively. The calcium phosphate dibasic dihydrate (Brushite) and HA utilized for the current study have unreported particle size. The hygroscopic nature of these materials can lead to the formation of large clumps, making the characterization of individual particle size difficult. Moreover, the manufacturers (Sigma-Aldrich and Fisher) do not quantify the specific particle size for these materials due to the variability in water content, yielding variations in particle size. Zirconium dioxide (ZrO 2 ) (Fisher), with particle size in the range 12-15 mm, was used as the radiopacifier. The commercial cement, PMMA-K, was used as indicated. PMMA-K is manufactured with similar compounds (PMMA, MMA, BPO, DMPT) having barium sulfate (BaSO 4 ) as the radiopacifier agent. Machined tools, including stainless steel 15 cm long eight gauge cannulas (1 ml in volume) were used for cement injection. 17 For PMMA-K, the powder and liquid were mixed using its commercial kit, which included eight gauge cannulas with 1.5 ml volume, for cement injection. Bondo resin (3M, St. Paul, MN) was used to create custom VB endplate potting dishes for use in loading the VBs during testing.
Cement Preparation
The cements investigated here were developed as described in previous studies. [18] [19] [20] The cement compositions (PMMA-HA, PMMA-Brushite) were compared with a commercially available cement (PMMA-K). In summary, the composite cements were prepared at a powder-to-liquid ratio of 1.65:1, and had equal concentrations of PMMA and their respective fillers, with Zirconium dioxide (ZrO 2 ) as the radiopacifier. The cements contained a fixed concentration of initiator BPO and accelerator DMPT, 1.25% w/v and 0.7% v/v, respectively (w/v referring to the percent amount of the compound in relation to the PMMA weight or MMA volume). [18] [19] [20] [21] [22] [23] The composite cements contained 10% w/w ZrO 2 as radiopacifer. The two composite cements in this study were chosen, after a series of tests on different formulations, as the best suited for use in spinal augmentation. 18, 20 These cements were highly filled (high powder-to-liquid ratios), premixed, mechanically stable, and easily injectable. The cements were stored at 4˚C, and were allowed to reach room temperature before injection into the VBs. PMMA-K is offered with a powder-to-liquid ratio of 20:9, uses a methylmethacrylate-styrene-copolymer (68% w/ w), and includes Barium sulfate (BaSO 4 ) (30% w/w) as the radiopacifier.
Bone Mineral Density DEXA scans (GE Lunar Prodigy Advance, Pittsburgh, PA) were used to quantify BMD in the spines. The scans were run in standard mode at 76 kV, 3.0 mA, and dose of 37 mGy.
The BMD values and T-scores were calculated using the scanner software (enCORE V.14.10), with the values adjusted according to specimen height and weight.
Specimens
The tests in this study were performed on two functional spinal unit (2FSU) segments which contain three VBs with the central VB, being the VB of interest, bounded by a disc, and VB superiorly and inferiorly. Five full human cadaveric spines (Table 1) were obtained from the Willed Body Program at The University of Texas Southwestern Medical Center (UTSW, Dallas, TX). The specimens were prepared by removing the soft tissue, ribs, and sectioning each spine into 5 2FSU segments. The ligaments in the segments were kept intact. Each segment, spanning three VBs between T2 and L4, was labeled one to five moving downwards. Hence, the segments studied were T2-T4, T5-T7, T8-T10, T11-L1, and Thus, a total of 25 2FSU segments were available for testing. The 2FSU segments were then randomized into three treatment groups PMMA-K, PMMA-Brushite, and PMMA-HA with nine, eight, and eight segments, respectively. The segments were then stored at À4˚C and were thawed for 24 h in open air prior to testing. The segment height was measured using a caliper at four sites: Anterior, posterior, transverse right, and transverse left. Measurements were taken pre-fracture, post-fracture, post-VP, and after every fatigue testing sequence with the segment height being the calculated average. Fluoroscopy (ARCADIS Orbit 3D, Siemens, Washington D.C), used during the void creation and VP treatment steps (described in detail below), was also used to track initial and post-VP height. Fluoroscopic height measurements were performed using SketchUp software (Trimble Navigation, Sunnyvale, CA) in which 2FSU height was measured at three points; anteriorly, medially, and posteriorly. The heights were corrected using the height of a standard marker (US 25 cent coin) as reference.
Void Creation
To ensure failure of the central VB in the 2FSU unit, the Xpander II Bone Tamp system (Medtronic, Minneapolis, MN) was used to create a void within the VB by balloon inflation. This ultimately weakened the structure of the central VB leading to its collapse. The balloon was inflated anteriorly to allow for the formation of a wedge fracture upon loading. Conray Iothalamate Meglumine 60% (Mallinckrodt, St Louis, MO) was used as the contrast media to visualize balloon expansion.
Fracture Induction
Fracturing of the segments was performed in air using a Material Testing System (MTS Bionix, MTS System Corp., Eden Prairie, MN). Segment height was first measured, followed by the application of a constant preload equal to 60% of the cadaver body weight for 2 min. This was followed by an increasing monotonic compression applied using a displacement controlled rate of 5 mm/min with force recorded simultaneously. 24, 25 Compression was stopped when yield was first observed in the force-displacement curve; this yield point was used as indication for fracture. [24] [25] [26] [27] Stiffness was determined from the linear slope of this initial force-displacement curve (intact stiffness). Segment height was re-measured post-fracturing and change in height was recorded. The change in height was calculated as a percent change with respect to the initial height. Fracture sites were also noted during the procedure. The VBs were potted in order to equally distribute the load, creating fractures at the weakest points in the structure.
Treatment
The 2FSU specimens were kept at room temperature for at least 24 h before VP. An 8-gauge needle was used to inject cement (medially and anteriorly). Cement was injected in the central VB under fluoroscopy until a complete endplate-toendplate fill was achieved. 28 Extravasation was assessed at this stage by measuring the mass of cement, if any, leaching out of the VB confines using an analytical balance (Mettler Toledo, Columbus, OH).
Fatigue Testing
The fatigue tests were performed using a Materials Testing System equipped with an environmental chamber. The chamber was filled with 1X PBS maintained at 37˚C. After treatment by cement augmentation, segment height was re-measured. The VBs were then subjected to the same aforementioned preload. The preload was then taken off and the specimen was loaded in compression at 5 mm/min until half the yield force was achieved in order to collect new stiffness data. 29 Specimens were then loaded sinusoidally at 2 Hz from 60% to 130% of body weight for 10,000 cycles. 30 Monotonic compressive loading was performed after the 10,000 fatigue cycle segment to collect stiffness data. If the VB was not damaged (i.e., damage defined as a height decrease greater or equal to 10%, measured under no load), the upper loading limit was increased to 150% of body weight and the fatigue testing protocol was run for another 10,000 cycle sequence. If, at this point, the VB was not damaged, the upper load was increased to 170% of the body weight and the test was run for a further 10,000 cycles. If, at this point, the VB was not damaged, the upper load was increased to 200% of the body weight and the test was run for a further 10,000 cycles. Monotonic loading was used to collect forcedisplacement data and calculate segments stiffness after Figure 1 . The steps of the mechanical study are shown. From left to right the 2FSU spine segment is being fractured, injected with cement, and cyclically tested.
PREMIXED COMPOSITE CEMENTS IN CADAVERIC MODEL
2069 every fatigue sequence. Percent height change was calculated for the segments after every sequence. Images of the mechanical testing steps are shown in Figure 1 .
Cement Interdigitation
The fatigue tested VBs treated, were cut transversely using a bench top abrasive saw (MEGA-M250, Pace Technologies, Tucson, AZ) in order to visualize cement interdigitation within the trabecular network. The cut VBs were imaged using a Keyence VHX HDR microscope (Keyence Corporation of America, Itasca, IL) at 5-10Â magnification. The cement interdigitation was visually assessed to check for any cement clumping, as well as possible extravasation points through the outer shell.
Statistical Analysis
One-way Analysis of Variance (ANOVA), with multiple comparison tests across values was performed to determine if differences exist between the groups at a confidence interval of 95% using MATLAB (R2012a, Natick, MA). The multiple comparisons performed provided information of significance between pairs of means. The multiple comparisons across values test utilizes a one-way ANOVA test to compare means of data to a control group. In this way, the p-value of the ANOVA could be validated and the means of data could be compared to the control.
RESULTS
Bone Mineral Density
After scanning and adjusting for specimen height and weight, the spines were found to be osteopenic with T-scores between À1 and À2. The results and spine details are shown in Table 1 .
Void Creation
Voids were successfully created through balloon inflation within the central VBs of the 2FSU segments. Figure 2 (left) shows the expanded balloon tamp in a T9 VB.
Fracture Induction
The 2FSU segments were successfully fractured and visualized under fluoroscopy as shown in Figure 2 (mid). The average yield force was 2.47 AE 1.10 kN, with slightly greater forces recorded for the larger segments (T11-T12-L1, L2-L3-L4). Wedge fractures were observed in the central VB; however some segments showed signs of fracture in the superior VB as well. There was a significant decrease in height post-fracture (average 20.39 AE 0.83 %, p < 0.05) as seen in Figure 3 .
Treatment
Three segments, one from each cement group, were too small for treatment and therefore omitted from the study. Therefore, the composite cement groups contained seven tested segments each, and the PMMA-K group included eight segments. Endplate-to-endplate fill was achieved through cement injection for all three cement groups investigated. Figure 2 (right) shows a PMMA-brushite filled VB. No extravasation was noted during treatment. Post-VP height change with respect to the post-fracture height can be seen in Figure 3 , and shows a slight average height increase of 5.93 AE 0.54% for all cement groups. Stiffness post-VP was lower relative to the average initial stiffness of 0.61 AE 0.34 kN/mm, but the difference was not significant (p > 0.05) (Fig. 4) .
Fatigue Testing
Changes in VB height were tracked after every cycling sequence and are relative to the post-VP height. The average height changes for the cement types can be seen in Figure 3 . Not all the 2FSU segments endured all four cycle sequences; only 38% of the PMMA-K treated segments reached sequence 4, whereas 57% of both PMMA-brushite and PMMA-HA reached sequence 4. The ratio of 2FSU segments that failed (reached the 10% height decrease threshold) were 5/8, 4/7, and 4/7 for PMMA-K, PMMA-brushite, and PMMA-HA, respectively. The majority of those failures occurred after sequences two and three with 4/13 and 5/13, respectively. Two segments failed after the first sequence and two failed after the fourth. The stiffness values for all cement groups experienced a significant The average changes in segment height after the different steps are shown for the three cement groups. There was a significant decrease in height for all the segments after fracturing. A slight restoration in height was observed after treatment. Ten percent decrease in height was set as the failure threshold for the fatigue sequences. The average height decreases were comparable for the three cements and were less than the 10% threshold. 
DISCUSSION
The purpose of this study was to investigate two recently developed pre-mixed composite cements in an anatomically relevant human cadaveric vertebroplasty model. Loss in bone mass is a contributing factor to VB weakening. In the current study, the specimens were all alike in this regard as their BMD values identified them as osteopenic. Increased porosity in the VB trabecular structure severely reduces the VB's ability to resist fracture. In addition to this, voids were created to exaggerate the loss in fracture resistance within the central VB of each 2FSU segment. 31 This was to ensure the fracturing of the central VB, as this was our primary interest during the tests. Other techniques have been employed to ensure the central VB fracturing, such as PMMA injection in the superior and inferior VBs, increasing their stiffnesses. 32 Weakening the central VB through void creation was more relevant to bone mass loss and therefore was the technique of choice.
All the 2FSU segments were successfully fractured at the central VB. The segments had comparable initial stiffness, however the yield forces were slightly greater for the larger segments (T11-T12-L1, L2-L3-L4). The fracturing procedure resulted in a significant height decrease in all the VB segments (Fig. 3) . The created wedge fractures were visualized in Figure 2 with fluoroscopy during the treatment Figure 4 . The average stiffness values for the three cement groups are shown. There was no significant difference between the three cements after the different testing steps. Stiffness was not restored post-VP treatment, however the VBs were reinforced in order to withstand the loading cycles. The stiffness values increased after the cycling sequences. Asterisks denote significant (p < 0.05) changes with respect to initial stiffness. process. Wedge fractures are the most common form of osteoporosis-induced VCFs. 4 The loss of bone mass and quality in the VB degrades the mechanical strength of the structure. Wedge fractures can occur when load on the anterior VB increases with flexion during movements such as bending over. The change in load distribution can result in a fivefold increase in load on the anterior section of the vertebrae. 4 Despite this, the monotonic compression used during the fracturing procedure mimicked that of trauma cases which usually create crush fractures. The wedge fractures visualized were a result of the void creation in the anterior portion of the VB. Some studies that mimic wedge fracture formation compress the VBs in flexion, resulting in an asymmetric load distribution. Nevertheless, the developed cements were envisioned for use in the stabilization of all types of VCFs, therefore the fracturing procedure was suitable for the study.
All three cements were successfully injected under fluoroscopy until an endplate-to-endplate fill was achieved, as visualized in Figure 2 . In a previous porcine model, 20 cement was injected at a volume equal to 30% of the VB volume. Studies have shown that adequate stiffness restoration is achieved at a relatively low 30% fill, thereby decreasing the risk of extravasation. 27, 29 Despite this, an endplate-to -endplate fill is necessary to provide proper transmission of loads through the centrum of the VB and not through the outer shell. 28 The vertebroplasty procedure, even though shown to be less effective in height restoration compared to balloon kyphoplasty, did result in a slight VB height increase for all cement groups, as seen in Figure 3 . The cement injection was not able to restore stiffness to initial values, however it did stabilize the structure to withstand the applied cyclical loads, as shown in Figure 4 . This is consistent with previous reports on VB stiffness post-VP. 20, 32 The 2FSU segments underwent a maximum of four fatigue sequences with maximum load increases from one sequence to the next. The cement groups were compared by the number of sequences reached before fatigue failure, defined as a 10% height decrease in the segment, and the number of failed segments. The segment stiffness was tracked after every sequence and for all cement groups increased to initial values after the cycling sequence. This trend of stiffness increase after loading, depicted in Figure 4 , is similar to that observed with bone. It is speculated that as trabecular bone is loaded there is storage of energy in the structure and a compaction of the rods and plates which can translate to stiffness increase. Similar to the previously performed porcine study, 20 the VB stabilization achieved through cement injection is a result of the interdigitation of cement through the trabecular network, enabling load transfer through the cement. It is a structural reinforcement, without factoring in osseointegration and bone regeneration which would require an in vivo model to analyze. The cement groups in this study all provided favorable stabilization in the fractured VB, resulting from adequate interdigitation. The observed result can be explained by understanding bone density. In the porcine study previously mentioned, the low interdigitating commercial cement failed to penetrate the densely packed network, and therefore was the worst performing cement. In this cadaver study, the VBs are osteopenic, with low bone densities, making interdigitation and subsequent reinforcement easier. This low bone density will be common in osteoporosis-induced VCFs. It is important to note that even with a higher BMD, a human VB will still be less dense compared to a porcine VB. A study on cement injection into non-osteopenic cadaveric VBs may further shed light on injection pressures and interdigitative abilities of different cements.
In an effort to assess performance characteristics of cements to interdigitation, it was crucial to visualize the cements within the trabeculae of the VBs. This also enabled the assessment of any risk of potential extravasation. Figure 5 shows images from the three cement groups. All groups showed desirable integration, with no clumping. The low bone packing in the osteopenic VBs facilitated cement interdigitation, as the cement is subjected to lower resistance upon injection. The cements shear-thinning ability allows for ease of injection at higher pressures. Upon CaP filler introduction, commercial cements have shown degradation in rheological properties leading to poor handling. [15] [16] [17] The pre-mixed system was able to incorporate the added Brushite and HA without any detrimental effects on cement handling and pseudoplasticity. Therefore, injection through cannulas was attainable, despite the cements' high initial viscosity. This is due to the increased swelling time in the premixed system allowing for complete integration of the CaP phase with the acrylic phase, ultimately forming homogenous cement. With these advantages, the premixed composite cements performed comparatively, if not superior to, the compared commercial cement and therefore show potential for use in spinal augmentation procedures.
The strengths of this study include the use of 2FSU segments providing a more realistic anatomical configuration to study VP with load bearing discs and VBs above and below the VB of interest. 31, 33 The current study however does have inherent limitations, with some aforementioned. The commercial cement is indicated for use with balloon kyphoplasty and not vertebroplasty, however, it has consistently served as a proper control in other studies. 18, 20 The fracture loading distribution mimics VB crush fractures encountered in trauma patients, and not osteoporosis-induced anterior wedge fractures. However, the creation of the void anteriorly allowed for the formation of a wedge fracture. The developed cements are envisioned for patients with all types of vertebral compression fractures, so this procedure suited the goals for testing. The study does not consider the in vivo physiochemical and cellular interactions that may affect the post-augmentation behavior of the cements. The bioactivity of the CaP phase in composite cements is isolated in this study, and it would require an animal model to understand osteoblast and osteoclast activity when in contact with this phase. Future studies, utilizing an animal model to analyze the performance characteristics and regenerative potential of the composite cements, are needed.
CONCLUSION
In conclusion, the novel pre-mixed composite PMMA-CaP bone cements adequately augmented the fractured VBs. The performance of the novel premixed composite cements was comparable to the commercial cement used here as a control. The cadaveric 2FSUs provided a more anatomically accurate model as compared to previous studies performed using a porcine vertebroplasty model. Future in vivo studies analyzing the bioactivity of the PMMA-CaP cements are needed to investigate the potential for osseointegration and bone regeneration. The initial results presented here show the potential for superior VCF correction via VP augmentation using these novel cements.
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